Table 2. Clinical management of in-hospital patients and outpatients.
| Clinical management, n (%) | In-hospital n = 1,094 (65.1%) | Outpatient n = 589 (34.9%) |
|---|---|---|
| Supportive medicinesa | ||
| Azithromycin | 618 (56.5) | 193 (32.9) |
| Antibiotics (other than azithromycin) | 774 (70.7) | 92 (15.7) |
| High-dose steroids | 477 (43.6) | 73 (12.5) |
| Anticoagulants | ||
| Prophylactic dose | 324 (29.5) | 11 (1.9) |
| Therapeutic dose | 96 (8.8) | 2 (0.3) |
| (Hydroxy)chloroquine | 175 (16.0) | 16 (2.7) |
| Oseltamivir | 182 (16.6) | 133 (5.6) |
| Ivermectin | 102 (9.3) | 83 (14.2) |
| Nitazoxanide | 5 (0.5) | 8 (1.4) |
| Management of immunosuppressive schedule | ||
| Antiproliferative drug reduction or withdrawal | 385 (37.2) | 87 (14.8) |
| CNI reduction or withdrawal | 48 (4.4) | 5 (0.9) |
| Complete withdrawal | 398 (36.4) | 1 (0.2) |
| No change | 280 (25.6) | 492 (84.0) |
CNI, calcineurin inhibitor.
Footnote:
a The sum of variables is > 100% because the patients could have received more than one clinical management option.